Press Releases

2021

Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress

Dec 3, 2021

Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories

Dec 3, 2021

Marizyme is Pleased to Announce the Appointment of David Barthel as CEO

Nov 16, 2021

Marizyme, Inc. Issues Letter to Shareholders

Mar 31, 2021

Marizyme Announces New Distribution and Channel Partnership for Chilean Market with Abdera

Mar 04, 2021

Marizyme, Inc. Appoints Veteran Business Executive Julie Kampf to Board

Feb 04, 2021

Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems

Feb 01, 2021

Marizyme Announces Approval for DuraGraft® in India

Jan 14, 2021

Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf

Jan 11, 2021

Marizyme, Inc. to Present at Biotech Showcase 2021 During the J.P. Morgan Healthcare Conference Biotech Showcase Digital, BIO @ JPM During “J.P. Morgan Week 2021”

Jan 07, 2021

2020

Marizyme, Inc. Expands Executive Team, Board of Directors

Dec 04, 2020

Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors

Nov 06, 2020

Marizyme and SBH Nutrition Science Agree to Develop Krillase(R) Based Dental Products for Pets

Oct 27, 2020

Marizyme Announces European DuraGraft(R) Registry Results Presented at the European Association for Cardio-Thoracic Surgery (EACTS) 34th Annual Virtual Meeting

Oct 09, 2020

Univest Securities, LLC. Announces Closing of Somulation, Inc. Acquisition and $7 Million Private Placement for its Client Marizyme, Inc.

Sep 29, 2020

Marizyme, Inc. Completes Acquisition of Somahlution, Inc. and Raises $7.0 Million in Private Placement

Sep 29, 2020

Marizyme, Inc., Engages Dr. Pamela Milla as Advisor to Begin Distribution in South America

Apr 26, 2020

Marizyme and Somahlution Announce Agreement with Leipzig Heart Center to Use DuraGraft in Patients undergoing Coronary Artery Bypass Surgery

Apr 08, 2020

Marizyme, Inc. Hires Ralph Makar as Chief Executive Officer

Feb 24, 2020

Duragraft Receives SGK National Reimbursement in Turkey

Feb 18, 2020

2019

Marizyme, Inc. Agrees to Acquire All Assets of Somahlution

Dec 17, 2019

Marizyme, Inc., Agrees to Distribute Somahlution’s DuraGraft Products in South America and Mexico

Oct 11, 2019

OTC Markets Group Welcomes New OTCQB Companies

Jul 31, 2019